HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis.

AbstractBACKGROUND:
A high glucose content in peritoneal dialysis (PD) solution may result in unfavorable changes on peritoneal character and worsened metabolic profiles. We conducted this retrospective cohort analysis to investigate the impact of initial glucose load on long-term outcomes of PD patients.
METHODS:
A total of 90 patients newly started on PD were enrolled. All subjects were divided into low, medium, or high glucose load equally in patient number according to the average dialysate glucose concentration prescribed in the first 6 months from PD initiation. Cox's regression was used for survival analyses and linear regression was used for analyses of determinants for glucose load.
RESULTS:
The mean follow-up period was 40.1 +/- 11.8 months. Patients with higher glucose load showed a significantly worse cumulative technique survival (log rank p = 0.002). In Cox's regression analysis, patients with lower glucose load had significantly better technique survival (p = 0.035). In linear regression analysis, preexisting diabetes mellitus (p < 0.001), lower serum albumin (p = 0.012), and lower weekly renal Kt/V (p = 0.019) were significantly correlated with higher glucose load.
CONCLUSIONS:
Higher glucose load during the initial period of PD was associated with higher prevalent diabetes mellitus, lower serum albumin, and lower residual renal function, and effectively predicted worse survival of PD therapy.
AuthorsHon-Yen Wu, Kuan-Yu Hung, Jenq-Wen Huang, Yung-Ming Chen, Tun-Jun Tsai, Kwan-Dun Wu
JournalAmerican journal of nephrology (Am J Nephrol) Vol. 28 Issue 5 Pg. 765-71 ( 2008) ISSN: 1421-9670 [Electronic] Switzerland
PMID18434715 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2008 S. Karger AG, Basel.
Chemical References
  • Serum Albumin
  • Glucose
Topics
  • Cohort Studies
  • Diabetes Complications
  • Female
  • Glucose (adverse effects)
  • Humans
  • Kidney (physiopathology)
  • Male
  • Middle Aged
  • Peritoneal Dialysis (mortality)
  • Regression Analysis
  • Retrospective Studies
  • Serum Albumin (analysis)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: